USA –The FDA announced that it has approved Eli Lilly’s injected drug tirzepatide, marketed under the brand name Mounjaro, to help improve blood sugar control in adults with type 2…
Read MoreLilly’s blockbuster diabetes drug wins FDA approval
Category: WORLD NEWS
Global Fund unveils strategy to reduce deaths from AIDS, TB, and malaria
SWITZERLAND – The Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these long-standing pandemics by 2030, Health Policy Watch…
Read MoreFDA OKs BD’s newest molecular diagnostics machine and its first test
USA – BD (Becton, Dickinson and Company) a global leader in medical technology, has announced the FDA approval of its new, fully automated, high-throughput infectious disease molecular diagnostics platform in…
Read MoreFDA approves Medtronic’s Onyx Frontier drug-eluting stent for treating CAD
USA – The US Food and Drug Administration (FDA) has approved the Onyx Frontier drug-eluting stent (DES) to treat patients with coronary artery disease (CAD), the device manufacturer, Medtronic has…
Read MoreMedtronic closes its deal on US$1.1B Intersect ENT acquisition
USA – Dublin-based device maker Medtronic has completed the US$1.1 acquisition of medtech firm Intersect ENT after satisfying US Federal Trade Commission’s (US FTC) regulatory conditions. The FTC announced earlier…
Read MoreUS NIH warrants Covid-19 technologies to WHO and MPP
SWITZERLAND –The US National Institutes of Health (NIH) has agreed to license 11 Covid-19 technologies to the Medicines Patent Pool (MPP) via the World Health Organization’s Covid-19 Technology Access Pool…
Read MoreFirst simulated patient treatment performed in Hospital-based BNCT Facility in Europe
FINLAND – -Neutron Therapeutics, a targeted radiation therapy company developing Boron Neutron Capture Therapy (BNCT), and Cosylab have announced that Neutron Therapeutics’ nuBeam BNCT System, has reached an important milestone…
Read MoreRegulatory approvals delay CSL’s US$11.7 billion takeover of Vifor Pharma
AUSTRALIA – Australian biotech giant CSL announced that the regulatory review of its US$11.7 billion acquisition of Switzerland’s Vifor Pharma been postponed as antitrust investigations continue. The acquisition will take…
Read MoreHealth and wellness startup FlexifyMe raises US$300K in seed round
INDIA – FlexifyMe, one of India’s fastest-growing Health and wellness platforms has raised US$ 300,000 in a seed funding round. Prominent investors in the round included Ravi Bhushan, Founder &…
Read MoreHologic secures FDA approval for Aptima CMV Quant assay, poised to challenge Abbott, Roche
USA – Hologic, a medical technology company based in the United States, has received FDA approval for its Aptima CMV Quant assay. The test has been approved to assess cytomegalovirus…
Read More